The metabolic puzzle during the evolution of HIV infection
- 31 October 2001
- journal article
- review article
- Published by Elsevier in Clinical Nutrition
- Vol. 20 (5) , 379-391
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Tumour necrosis factor, a key role in obesity?FEBS Letters, 1999
- Metabolic abnormalities and use of HIV-1 protease inhibitorsThe Lancet, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapyThe Lancet, 1998
- A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and Ω-3 fatty acids in HIV-infected patientsAIDS, 1998
- Relationship of Plasma HIV-RNA Levels and Levels of TNF-α and Immune Activation Products in HIV InfectionClinical Immunology and Immunopathology, 1997
- Energy metabolism in cancer and human immunodeficiency virus infectionProceedings of the Nutrition Society, 1997
- Energy Expenditure in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1997
- Serum cortisol and DHEA concentrations during HIV infectionPsychoneuroendocrinology, 1997